Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Ya-Qin Wang; Yu Zhang; Wei Jiang; Yu‐Pei Chen; Shuoyu Xu; Na Liu; Yin Zhao; Li Li; Lei Yuan; Xiao-Hong Hong; Ye‐Lin Liang; Junyan Li; Lulu Zhang; Jing‐Ping Yun; Ying Sun; Ying‐Qin Li; Jun Ma

doi:10.1186/s40425-019-0752-4

November 13, 2019Journal for ImmunoTherapy of CancerOpen Access

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

We determined the expression status of nine immune checkpoints consistent with 13 features in NPC and further constructed an ICS prognostic model, which might add prognostic value to the TNM staging system.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2019) studied this question.

synapsesocial.com/papers/69d9d6b184371aa676a3c023 https://doi.org/10.1186/s40425-019-0752-4

View Full Paper

Ask AI

Bookmark

Share

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Ask about this paper

Abstract

Discussion

Cite This Study

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading